Carvedilol Tablet
Carvedilol is a non-selective beta-blocker with alpha-1–blocking activity. It reduces heart rate, lowers blood pressure, decreases cardiac workload, and has antioxidant properties.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider carvedilol for patients with chronic heart failure or dilated cardiomyopathy (DCM) where modulating the body's neurohormonal response is a clinical objective. It is also frequently a point of discussion for the management of systemic hypertension or certain cardiac arrhythmias, particularly when traditional beta-blockers may not provide the desired physiological profile. By utilizing a multi-receptor approach, your veterinarian can manage the workload on the heart while simultaneously addressing the constriction of peripheral blood vessels.
At a pharmacological level, carvedilol acts as a competitive antagonist at beta-1, beta-2 and alpha-1 adrenergic receptors. By blocking beta-1 receptors in the heart, the medication manages the heart rate and lessens the force of contraction, which may help address myocardial oxygen demand. Its alpha-1 blocking activity facilitates peripheral vasodilation, which manages the resistance against which the heart must pump (afterload). Unlike first-generation beta-blockers, carvedilol also notable in its antioxidant and anti-proliferative properties, which veterinarians consider when addressing the long-term remodeling of cardiac tissue. Your veterinarian will determine the clinical appropriateness of carvedilol based on your pet’s diagnostic findings, such as echocardiography and their current hemodynamic stability.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of carvedilol include localized digestive changes such as vomiting or a decrease in appetite. Because it influences the heart’s electrical and mechanical activity, some pets may exhibit behavioral shifts including lethargy, a slow heart rate (bradycardia) or weakness associated with low blood pressure. Your veterinarian will typically recommend a gradual introduction of the prescriptions and monitor for any signs of respiratory effort or fluid accumulation, as beta-blockade can occasionally influence heart failure status during the initial titration phase.
This medication is typically used with extra caution or avoided in patients with known severe bradycardia, advanced heart block or overt, decompensated heart failure. It is also carefully evaluated in pets with bronchial disease or asthma, as beta-2 blockade can influence airway diameter. Before starting a protocol, ensure your veterinarian has a complete history of all other medications your pet is receiving, especially other blood pressure medications, digitalis or calcium channel blockers. Owners should monitor their pet for any unusual weakness or fainting episodes and contact their veterinarian promptly with any concerns. Your veterinarian is the right person to provide guidance on the necessary monitoring and the proper administration schedule to ensure the management approach remains suitable for your pet's cardiac needs.
Yes. Carvedilol is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home.
Yes. While carvedilol is available in commercial tablet formats intended for human use, Mixlab specializes in compounding the active ingredient into customized strengths and flavored dosage forms—such as flavored oral liquids or smaller capsules—to suit the specific needs of dogs and cats. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians often discuss carvedilol as a "third-generation" beta-blocker because it has additional alpha-blocking properties that cause the blood vessels to relax. While older medications like atenolol primarily focus on slowing the heart rate, carvedilol provides a broader approach by also managing the pressure the heart has to pump against.
The most important observational signs to monitor include a sudden loss of energy, stumbling or a very slow heartbeat after starting the medication. Because carvedilol can lower blood pressure, you should contact your veterinarian immediately if your pet appears unusually weak or if they experience any episodes of collapse.
